Hybrid peptide with functions of regulating immunity, neutralizing and digesting endotoxin and resisting inflammation, and preparation method and application thereof
An immunomodulatory, hybrid peptide technology, applied in the field of genetic engineering and biological preparations, can solve the problems of increasing the complexity and antagonism of clinical drug selection, decreasing immunity and production performance, failing to improve the immune function of the body, and achieving weight reduction. As well as the effects of intestinal damage, tissue damage alleviation, good immunity and anti-inflammatory two-way regulation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0059] Example 1 Preparation of immune anti-inflammatory hybrid peptide LTA
[0060] 1. Obtaining the hybrid peptide sequence
[0061] By studying the sequence, structure and relationship between sequence structure and function of polypeptide LL-37 (sequence shown in SEQ ID NO.2) and thymosin Tα1 (sequence shown in SEQ ID NO.3), protein molecular design technology was used to The hybridization of polypeptide LL-37 and thymosin Tα1 was carried out to obtain multiple candidate hybrid peptides. In this example, the hybrid peptide LTA (sequence shown in SEQ ID NO.1), Tα1-LL-37 (sequence shown in SEQ ID NO.4) and LL-37-Tα1' (sequence shown in SEQ ID NO.5 shown) as an example to illustrate the screening process of immune anti-inflammatory hybrid peptide LTA.
[0062] Take advantage of the properties of myeloid differentiation protein-2 (MD-2) (i.e., MD-2 binds to TLR4, confers TLR4 responsiveness to various ligands including LPS; and MD-2 can promote the expression of TLR4 and TLR...
Embodiment 2
[0076] Example 2 The neutralization effect of hybrid peptide LTA on LPS
[0077] Dissolve and dilute the peptide LTA and its parent peptides LL-37 and Tα1 into solutions of different concentrations (0-64 μg / mL) using pyrogen-free endotoxin testing water, and take 100 μL of the above-mentioned peptide solutions of each concentration and LPS (1EU / mL) respectively. mL) mixed. After incubating at 37°C for 30 min, the neutralization rate of polypeptide LTA, LL-37, and Tα1 to LPS was detected using a chromogenic mechanism Limulus kit, and polymyxin B (PMB) was used as a control. The result is as Figure 5 As shown, the polypeptide LTA has a high LPS neutralization activity, and its LPS neutralization activity is equivalent to that of polymyxin B. When the concentration is 8 μg / mL, the neutralization rate of the polypeptide LTA to LPS is close to 100%, and its neutralization The activity was significantly higher than that of its parent peptide LL-37 and Tα1.
Embodiment 3
[0078] Example 3 Effect of Hybrid Peptide LTA on Survival Rate of Mouse Macrophage Cells
[0079] The macrophage RAW264.7 in the logarithmic growth phase was inoculated in a 96-well plate, and the initial cell culture density was 1×10 4 cells / mL, 100 μL per well, at 37°C, 5% CO 2 After culturing overnight under certain conditions, a series of concentration gradient LTA, LL-37 and Tα1 (0-100μg / mL) solutions were added, and after culturing for 24 hours, the effect of polypeptide LTA on the survival rate of mouse macrophages was detected by CCK8 method . The result is as Image 6 As shown, the cytotoxicity of polypeptide LTA was significantly lower than that of its parent peptide LL-37, and the survival rate of macrophages was greater than 83% in the concentration range of 0-100 μg / mL, indicating that LTA has low cytotoxicity and high security.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com